Adenoviruses have been used as delivery vectors in gene therapy applications for several decades, largely for cancer therapy applications, but they are rapidly gaining interest in the vaccinology community due their potency as vaccines for infectious disease. This talk will provide an overview of the background of Ad vectors, their limitations and promise for the future.